Volltext-Downloads (blau) und Frontdoor-Views (grau)

Cost-effectiveness Study of Antihypertensive Drugs in Mumbai, India

  • Hypertension is a serious global public health problem. It accounts for 10% of all deaths in India and is the leading noncommunicable disease.1 Recent studies have shown that the prevalence of hypertension is 25% in urban and 10% in rural people in India.2 It exerts a substantial public health burden on cardiovascular health status and health care systems in India.3 Antihypertensive treatment effectively reduces hypertension-related morbidity and mortality.1 The cost of medications has always been a barrier to effective treatment.

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar


Author:Dnyanesh LimayeORCiDGND, M. Kale, N. Chitre, D. Deshapande, R. Desai, Vaidehi Limaye, Gerhard FortwengelORCiDGND
Parent Title (English):Current Therapeutic Research
Document Type:Article
Release Date:2016/07/14
Tag:India; antihypertensive; cost-effectiveness; hypertension
First Page:S2
Link to catalogue:1685452329
Institutes:Fakult├Ąt III - Medien, Information und Design
DDC classes:610 Medizin, Gesundheit
Licence (German):License LogoCreative Commons - CC BY-NC-ND - Namensnennung - Nicht kommerziell - Keine Bearbeitungen 4.0 International